In a recent clinical trial of Novo Nordisks Wegovy (semaglutide) drug product with nearly 2,000 participants, approximately 70% of participants achieved a weight loss of at least 10%, and approximately 50% achieved a weight loss of at least 15%
This medication is administered as a once-weekly injection and is ideal for individuals with a BMI of 30 or higher, or a BMI of 27 with weight-related health conditions
However, since furosemide has a broad therapeutic index and is generally dose-adjusted individually, and since rosuvastatin is generally well-tolerated with similar increases in exposures previously being reported as not clinically relevant, the results observed in the present trial are expected to be of no clinical relevance
Unlike drugs that are heavily metabolized by your liver, tirzepatide's mechanism focuses on activating specific hormone pathways rather than competing for enzyme systems
GPX3 mRNA is present in renal proximal tubular epithelial cells, and GPX3 may have specific antioxidant functions in the renal tubules or extracellular spaces due to the higher concentration of GSH in the kidneys
10.1242/jcs.150029 36 TsaiS